Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Pharmather Holdings Ltd C.PHRM

Alternate Symbol(s):  PHRRF

PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The... see more

CSE:PHRM - Post Discussion

Pharmather Holdings Ltd > News...PD001 gets approval!!
View:
Post by Guytorule on Aug 19, 2024 8:57am

News...PD001 gets approval!!

Subsidiary "Sairiyo" gets Australian approval to commence trials for their drug PD001 phase 1 for responsive cancers and infectious deceases including Covid 19. Then applications to FDA for phase 2 and 3...Good news...now we wait for their KETARX  product FINAL APPROVAL by FDA with its goal date of October 29th  around the corner..
Comment by Guytorule on Aug 19, 2024 10:47am
This Sairiyo 49% subsidiary is now in play for merger and PharmaTher to acquire rest of of 51% and spin out this company publically..as stated by CEO many times. This Australian clincal trial approval is the catalysist to which a merger is required and for Sairiyo to go public and attract investor interest and financing that is required for Sairiyo. Sairiyo has a Market Cap of only $1million ...more  
Comment by Guytorule on Aug 19, 2024 10:54am
Buying opportunity for PharmaDrug (PHRX) listed on CSE company that owns the 51% and may be acquired by PharmaTher...which in it self waiting for their FDA approval very soon for Ketrax . Both these companies are buying opportunities..its a marriage thats needs to take place here with both companies in my opinion..all happenning soon. Good luck, ground floor investment..with massive upside.. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities